文献速递运动医学关节外科

基质诱导自体软骨细胞植入术后10年前瞻性临床与影像学评估及胫股与髌股移植结局比较

10-Year Prospective Clinical and Radiological Evaluation After Matrix-Induced Autologous Chondrocyte Implantation and Comparison of Tibiofemoral and Patellofemoral Graft Outcomes.
PubMed 文献 · Am J Sports Med · 2024-02-21

本研究前瞻性纳入2002年9月至2012年12月接受基质诱导自体软骨细胞植入术(MACI)的204例患者,评估10年临床与影像学结局并比较胫股与髌股移植。10年时168例可临床随访、151例移植可MRI评估;患者报告结局在术后2年内改善,2至10年多数稳定,92%患者对疼痛缓解满意,10年移植失败率9.3%,胫股组在生活质量、运动与娱乐及伸膝力量肢体对称指数上优于髌股组。

要点

  • MACI术后2年内患者报告结局显著改善,2至10年除伸膝力量肢体对称指数外无显著变化。
  • 10年时92%患者对疼痛缓解满意,76%对运动能力满意,MRI评估移植失败率9.3%。
  • 胫股组较髌股组10年生活质量、运动与娱乐评分及伸膝力量肢体对称指数更优。

核心结论

  • 本研究对接受MACI的前瞻性系列患者进行长期评估,显示10年时临床评分良好、患者满意度高且移植存活率可接受。
  • 胫股MACI较髌股MACI报告更好的长期临床结局,尽管MRI-based结局大体相似。

研究设计与样本

  • 病例系列研究,证据等级4级。
  • 2002年9月至2012年12月前瞻性注册204例接受MACI的患者,术前及术后2、5、10年评估。
  • 10年时168例可进行临床评估,151例移植(共182例移植)接受MRI评估。

主要发现

  • 所有患者报告结局指标在术后2年内改善(P < .0001)。
  • 除伸膝力量肢体对称指数显著增加(P = .004)外,2至10年间无其他患者报告结局指标或临床评分发生显著变化。
  • 末次随访时92%患者对MACI缓解膝关节疼痛满意,76%对参与运动的能力满意。
  • 2至10年间任何MRI-based MOCART变量或整体MRI复合评分均无显著变化。
  • 10年MRI评估的151例移植中14例(9.3%)失败,定义为移植分层或MRI扫描无移植组织;204例中36例无法长期评估,其中7例已行全膝关节置换、1例因早期移植失败在同侧股骨内侧髁部位行二次MACI,因此期间共22例(10.8%)实质上发生移植失败。

关键数值与推荐

  • 移植失败定义为MRI扫描显示移植分层或无移植组织。
  • 采用膝关节损伤和骨关节炎结局评分、疼痛频率与严重程度视觉模拟量表、满意度及等速峰值膝伸肌和屈肌力量评估。
  • 采用MOCART系统对MRI扫描进行移植评分,关注组织填充和整体MRI移植复合评分。

临床怎么用

  • 作者报告MACI在10年时临床评分良好、患者满意度高且移植存活率可接受。
  • 作者报告胫股MACI较髌股MACI的长期临床结局更好,尽管MRI-based结局大体相似。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Long-term outcomes in larger cohorts after matrix-induced autologous chondrocyte implantation (MACI) are required. Furthermore, little is known about the longer-term clinical and radiological outcomes of MACI performed in the tibiofemoral versus patellofemoral knee joint. PURPOSE: To present the 10-year clinical and radiological outcomes in patients after MACI and compare outcomes in patients undergoing tibiofemoral versus patellofemoral MACI. STUDY DESIGN: Case series; Level of evidence, 4. METHODS: Between September 2002 and December 2012, 204 patients who underwent MACI were prospectively registered into a research program and assessed preoperatively and at 2, 5, and 10 years postoperatively. Of these patients, 168 were available for clinical review at 10 years, with 151 (of a total of 182) grafts also assessed via magnetic resonance imaging (MRI). Patients were evaluated using the Knee injury and Osteoarthritis Outcome Score, a visual analog scale for pain frequency and severity, satisfaction, and peak isokinetic knee extensor and flexor strength. Limb symmetry indices (LSIs) were calculated for strength measures. Grafts were scored on MRI scans via the MOCART (magnetic resonance observation of cartilage repair tissue) system, with a focus on tissue infill and an overall MRI graft composite score. RESULTS: All patient-reported outcome measures improved (P < .0001) up to 2 years after surgery. Apart from the significant increase (P = .004) in the peak isokinetic knee extensor LSI, no other patient-reported outcome measure or clinical score had changed significantly from 2 to 10 years. At the final follow-up, 92% of patients were satisfied with MACI to provide knee pain relief, with 76% satisfied with their ability to participate in sports. From 2 to 10 years, no significant change was seen for any MRI-based MOCART variable nor the overall MRI composite score. Of the 151 grafts reviewed via MRI at 10 years, 14 (9.3%) had failed, defined by graft delamination or no graft tissue on MRI scan. Furthermore, of the 36 patients (of the prospectively recruited 204) who were not available for longer-term review, 7 had already proceeded to total knee arthroplasty, and 1 patient had undergone secondary MACI at the same medial femoral condylar site because of an earlier graft failure. Therefore, 22 patients (10.8%) essentially had graft failure over the period. At the final follow-up, patients who underwent MACI in the tibiofemoral (vs patellofemoral) joint reported significantly better Knee injury and Osteoarthritis Outcome Score subscale scores for Quality of Life (P = .010) and Sport and Recreation (P < .001), as well as a greater knee extensor strength LSI (P = .002). Even though the tibiofemoral group demonstrated better 10-year MOCART scores for tissue infill (P = .027), there were no other MRI-based differences (P > .05). CONCLUSION: This study reports the long-term review of a prospective series of patients undergoing MACI, demonstrating good clinical scores, high levels of patient satisfaction, and acceptable graft survivorship at 10 years. Patients undergoing tibiofemoral (vs patellofemoral) MACI reported better long-term clinical outcomes, despite largely similar MRI-based outcomes.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Ebert JR, Zheng M, Fallon M, et al. 10-Year Prospective Clinical and Radiological Evaluation After Matrix-Induced Autologous Chondrocyte Implantation and Comparison of Tibiofemoral and Patellofemoral Graft Outcomes. Am J Sports Med. 2024. PMID: 38384192. doi:10.1177/03635465241227969

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。